Boston Scientific (BSX)
(Delayed Data from NYSE)
$72.91 USD
+3.92 (5.68%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $73.06 +0.15 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *BMO4/24/24 |
---|---|
Current Quarter | 0.51 |
EPS Last Quarter | 0.55 |
Last EPS Surprise | 7.84% |
ABR | 1.29 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.25 |
Next Year | 2.54 |
EPS (TTM) | 2.05 |
P/E (F1) | 30.66 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.68B | 3.93B | 15.55B | 16.95B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 3.69B | 3.98B | 15.59B | 17.13B |
Low Estimate | 3.65B | 3.91B | 15.50B | 16.72B |
Year ago Sales | 3.39B | 3.60B | 14.24B | 15.55B |
Year over Year Growth Est. | 8.52% | 9.21% | 9.20% | 9.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.51 | 0.56 | 2.25 | 2.54 |
# of Estimates | 12 | 10 | 12 | 12 |
Most Recent Consensus | 0.51 | NA | 2.24 | 2.53 |
High Estimate | 0.51 | 0.59 | 2.27 | 2.57 |
Low Estimate | 0.50 | 0.54 | 2.24 | 2.50 |
Year ago EPS | 0.47 | 0.53 | 2.05 | 2.25 |
Year over Year Growth Est. | 8.51% | 5.66% | 9.76% | 12.68% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 0 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.51 | 0.56 | 2.25 | 2.54 |
7 Days Ago | 0.51 | 0.56 | 2.25 | 2.54 |
30 Days Ago | 0.51 | 0.56 | 2.25 | 2.54 |
60 Days Ago | 0.51 | 0.56 | 2.25 | 2.54 |
90 Days Ago | 0.52 | 0.56 | 2.23 | 2.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.51 | 0.56 | 2.25 | 2.56 |
Zacks Consensus Estimate | 0.51 | 0.56 | 2.25 | 2.54 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.95% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.55 | 0.50 | 0.53 | 0.47 | NA |
Estimate | 0.51 | 0.48 | 0.49 | 0.43 | NA |
Difference | 0.04 | 0.02 | 0.04 | 0.04 | 0.04 |
Surprise | 7.84% | 4.17% | 8.16% | 9.30% | 7.37% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more